PALO ALTO, Calif., Oct. 17, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced an 80-year-old male with head & neckcancer became the first patient in Europe to be treated on the Halcyon™ system at University Hospitals Leuven (UZ Leuven) in Belgium. Halcyon is an advanced cancer treatment
Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is designed to expand the availability of high-quality cancer care globally and help save the lives of millions more cancer patients. It is well suited to handle the majority of cancer patients, offering advanced treatments for lung, esophagus, brain, head & neck, and many other forms of cancer.
"We selected the Halcyon system because of its potential to accelerate the treatment workflow and allow for a much closer connection between the patient and therapist," said professor Karin Haustermans, MD, chair of the department, UZ Leuven. "Having now completed our first treatments I can say that Halcyon lived up to its promise of a more efficient workflow and better integration of imaging and treatment, which resulted in a much faster overall treatment time."
"We are very proud to have partnered with UZ Leuven on making Halcyon treatments available to patients in Europe just two months after the hospital ordered this new system," said Kolleen Kennedy, president of Varian's Oncology Systems business. "The treatments beginning at UZ Leuven are another important step in continuing our efforts of advancing cost-effective cancer care worldwide."
For more information on Halcyon, visit www.varian.com/halcyon
About Varian Medical SystemsVarian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press ContactMark PlungyVarian Medical Systems+1 (650) 424-5630 [email protected]
View original content:http://www.prnewswire.com/news-releases/uz-leuven-treats-first-patient-in-europe-on-varian-halcyon-cancer-treatment-system-300537606.html
SOURCE Varian Medical Systems
Subscribe to our Free Newsletters!
Leukoplakia refers to a painless, raised white patch in the mouth that does not go away on rubbing, ...
Health insurance has emerged one of the fastest growing segments in the non-life insurance industry ...
Strabismus or squint is a failure of the two eyes to maintain proper alignment when looking at an ...View All